BioAge Labs Cash Flow Statement (2024-2025) | BIOA

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -12.73M-13.51M-23.10M-21.59M-12.99M-21.55M-20.13M-25.72M
Depreciation and Depletion (Quarter) 0.03M0.10M0.10M0.08M0.04M0.10M0.10M0.06M
Share-based Compensation (Quarter) 0.85M1.56M1.85M2.72M2.95M3.23M2.79M2.72M
Gains from Investment Securities (Quarter) 0.01M0.27M0.05M-0.10M3.11M2.89M0.23M
Non-cash Items (Quarter) 59.49M1.02M0.15M0.27M5.49M46.25M
Cash from Operations (Quarter) -15.67M-15.78M-14.93M-5.14M-17.36M-19.97M-16.04M-28.25M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.03M0.10M0.10M0.08M0.04M0.10M0.10M0.06M
Change in Working Capital
Change in Receivables (Quarter) 0.36M0.24M-0.09M0.25M
Change in Account Payables (Quarter) 0.36M-1.57M1.34M-0.13M2.05M-2.60M3.65M-2.31M
Change in Accured Expenses (Quarter) -4.12M-1.66M8.20M2.21M-6.95M2.73M-0.54M1.35M
Other Working Capital Changes (Quarter) 1.62M0.02M10.86M1.18M-4.08M2.89M1.73M
Investing Activities
Capital Expenditures (Quarter) 0.04M0.30M0.03M0.43M0.16M0.02M0.11M
Change in Acquisitions & Divestments (Quarter) 25.75M26.00M
Cash from Investing Activities (Quarter) -0.04M-0.30M-0.03M-77.99M-15.64M12.84M-14.43M
Financing Activities
Other financing activities (Quarter) 0.50M0.77M-1.27M0.54M0.34M
Cash from Financing Activities (Quarter) 168.00M-2.39M190.68M24.90M-1.50M-1.50M-1.54M16.01M
Additional items
Exchange Rate Effect (Quarter) 0.02M-0.02M-0.06M0.14M-0.01M-0.05M-0.01M-0.02M
Change in Cash (Quarter) 152.35M-18.22M175.39M19.88M-96.86M-37.16M-4.76M-26.68M
Free Cash Flow (Quarter) -15.67M-15.82M-15.24M-5.16M-17.79M-20.13M-16.07M-28.36M
Net Cash Flow (Quarter) 152.33M-18.20M175.45M19.74M-96.85M-37.11M-4.75M-26.67M